In order to assess whether Tregs can be recruited to the tumor by factors released by the TM40D-COX2 cells, CD4+ CD25+ Tregs were enriched by magnetic column (MACS) from naïve thymus and lymph nodes (Figure 4A). This evidence concerns the gene PTGS2 and neoplasm.